FindTrial
Sign In

Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012

Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-003813-42-SE
Enrollment
Unknown
Registered
2006-11-07
Start date
2006-12-21
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program

Interventions

Product Name: corifollitropin alfa Product Code: Org 36286 Pharmaceutical Form: Solution for injection INN or Proposed INN: corifollitropin alfa CAS Number: 195962-23-3 Current Sponsor code: Org 36286

Sponsors

NV Organon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects from whom embryos have been cryopreserved in Trial 107012 of which at least one embryo is thawed for use in a subsequent FTET cycle; 2. Able and willing to give written informed consent. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Main Objective: To collect the outcome of frozen-thawed embryo transfer cycles after the embryos are cryopreserved in Trial 107012, in order to estimate the cumulative pregnancy rate for each treatment group.;Secondary Objective: ;Primary end point(s): Cumulative ongoing pregnancy rate; the cumulative ongoing pregnancy rate is the percentage of subjects who started controlled ovarian stimulation treatment in Trial 107012 and have an ongoing pregnancy either immediately after embryo transfer in Trial 107012 or after one or more frozen-thawed embryo transfer cycles following cryopreservation.—

Countries

Austria, Czech Republic, France, Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026